| Product Code: ETC8632646 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of plasmid DNA manufacturing into Nigeria saw significant growth in 2024, with Germany, India, UAE, Denmark, and the UK emerging as the top exporting countries. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), transitioned from moderate to high in 2024, indicating a more consolidated market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.88%, while the growth rate from 2023 to 2024 spiked to an impressive 28.4%, underscoring the increasing demand for plasmid DNA manufacturing in Nigeria.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Plasmid DNA Manufacturing Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Plasmid DNA Manufacturing Market - Industry Life Cycle |
3.4 Nigeria Plasmid DNA Manufacturing Market - Porter's Five Forces |
3.5 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.6 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume Share, By Development Phase, 2021 & 2031F |
3.7 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
4 Nigeria Plasmid DNA Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for plasmid DNA in research and development activities in Nigeria |
4.2.2 Government initiatives supporting biotechnology and pharmaceutical industries |
4.2.3 Growing investments in healthcare infrastructure in Nigeria |
4.3 Market Restraints |
4.3.1 High initial setup costs and technology barriers for establishing plasmid DNA manufacturing facilities |
4.3.2 Lack of skilled workforce and expertise in plasmid DNA manufacturing in Nigeria |
5 Nigeria Plasmid DNA Manufacturing Market Trends |
6 Nigeria Plasmid DNA Manufacturing Market, By Types |
6.1 Nigeria Plasmid DNA Manufacturing Market, By Grade |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Grade, 2021- 2031F |
6.1.3 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By R&D Grade, 2021- 2031F |
6.1.4 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By GMP Grade, 2021- 2031F |
6.2 Nigeria Plasmid DNA Manufacturing Market, By Development Phase |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Pre-Clinical Therapeutics, 2021- 2031F |
6.2.3 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Clinical Therapeutics, 2021- 2031F |
6.2.4 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Marketed Therapeutics, 2021- 2031F |
6.3 Nigeria Plasmid DNA Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By DNA Vaccines, 2021- 2031F |
6.3.3 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Cell & Gene Therapy, 2021- 2031F |
6.3.4 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3.5 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Nigeria Plasmid DNA Manufacturing Market, By Disease |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.4.3 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.4.4 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Genetic Disorder, 2021- 2031F |
6.4.5 Nigeria Plasmid DNA Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Nigeria Plasmid DNA Manufacturing Market Import-Export Trade Statistics |
7.1 Nigeria Plasmid DNA Manufacturing Market Export to Major Countries |
7.2 Nigeria Plasmid DNA Manufacturing Market Imports from Major Countries |
8 Nigeria Plasmid DNA Manufacturing Market Key Performance Indicators |
8.1 Percentage of RD expenditure in the biotechnology sector in Nigeria |
8.2 Number of collaborations between local biotech companies and international firms |
8.3 Investment inflow in biotech and pharmaceutical industries in Nigeria |
9 Nigeria Plasmid DNA Manufacturing Market - Opportunity Assessment |
9.1 Nigeria Plasmid DNA Manufacturing Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.2 Nigeria Plasmid DNA Manufacturing Market Opportunity Assessment, By Development Phase, 2021 & 2031F |
9.3 Nigeria Plasmid DNA Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Nigeria Plasmid DNA Manufacturing Market Opportunity Assessment, By Disease, 2021 & 2031F |
10 Nigeria Plasmid DNA Manufacturing Market - Competitive Landscape |
10.1 Nigeria Plasmid DNA Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Plasmid DNA Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |